Prospective association of lipoprotein(a) concentrations and apo(a) size with coronary heart disease among men in the Multiple Risk Factor Intervention Trial

Citation
Rw. Evans et al., Prospective association of lipoprotein(a) concentrations and apo(a) size with coronary heart disease among men in the Multiple Risk Factor Intervention Trial, J CLIN EPID, 54(1), 2001, pp. 51-57
Citations number
67
Categorie Soggetti
Envirnomentale Medicine & Public Health","Medical Research General Topics
Journal title
JOURNAL OF CLINICAL EPIDEMIOLOGY
ISSN journal
08954356 → ACNP
Volume
54
Issue
1
Year of publication
2001
Pages
51 - 57
Database
ISI
SICI code
0895-4356(200101)54:1<51:PAOLCA>2.0.ZU;2-I
Abstract
In this nested case-control study, lipoprotein (a) [Lp(a)] concentrations a nd apo(a) isoform size were measured in serum samples obtained from men par ticipating in the prospective Multiple Risk Factor Intervention Trial (MRFI T). Serum from men aged 35 to 57 years and stored for up to 20 years were a nalyzed for Lp(a) levels (n=736) and isoform size (n=487), respectively. Ca ses involved nonfatal myocardial infarctions (MI; n=98), documented during the active phase of the study that ended on February 28, 1982 and coronary heart disease (CHD) deaths (n=148) monitored through 1990. Median Lp(a) lev els did not differ between cases and controls and mean apo(a) size did not vary between cases and controls in the entire study population. When adjust ed for age and Lp(a) concentration, logistic regression analysis indicated that small apo(a) isoforms were associated with CHD deaths among smokers (O R 3.31; 95% CI 1.07-10.28). (C) 2001 Elsevier Science Inc. All rights reser ved.